CATHEPSINCYSTEINPROTEASEHEMMER

Patent europeic · EP1817276 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1817276
Numer da la dumonda
EP05808098
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
18-11-2005
Publitgà
15-08-2007
Concedì
08-08-2012
Stritgà
25-06-2024
Motiv
Taxa annuala betg pajada
Classas IPC
C07C 255/46 (2006.01)
A61K 31/275 (2006.01)
A61P 19/10 (2006.01)
Prioritad
US 630405 P 23.11.2004
Dumonda PCT
PCT/CA2005/001764 18.11.2005
Publicaziun PCT
WO2006/056047 01.06.2006
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-06-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.06.2024

  2. 01-12-2022

    Midada

    Published in Swissreg on 01.12.2022

  3. 16-10-2012

    Represchentant inscrit

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 16.10.2012

  4. 08-08-2012

    Concedì

    Published in Swissreg on 08.08.2012

Partidas

Possessur

Merck Canada Inc.

16711 Trans-Canada Highway, Kirkland, QC H9H 3L1, CA

Represchentant

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventur

GAUTHIER, Jacques, Yves

Kirkland, Québec H9H 3L1, CA

LI, Chun, Sing

Kirkland, Québec H9H 3L1, CA

MELLON, Christophe

Kirkland, Québec H9H 3L1, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.